Clinical Trial Update: Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating recombinant human erythropoietin effects on platelet function in patients with acute myocardial infarction; study completed with posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Recombinant human erythropoietin (erythropoietin)

Snippet

Sponsor: Yale University | Conditions: Myocardial Infarction | Phase 2 | Status: COMPLETED | Results posted: 2011-09-13